Ms. Anderson has covered many aspects of drug development during over 30 years in the pharmaceutical and biotechnology industry. Ms. Anderson has held several positions which have included the areas of regulatory affairs, drug development, and due diligence for licensing. She has arranged and been involved in meetings with many global agencies including the FDA, and the EMA, including a successful CHMP arbitration. In 2015 she was awarded the designation of Fellow by RAPS.